Effects of estradiol–drospirenone hormone treatment on carotid artery intima-media thickness and vertigo/dizziness in postmenopausal women

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Archives of Gynecology and Obstetrics

• Publication date

  2011-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00404-010-1487-0PMID 20443014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hormone replacement therapy and cardiovascular disease revisited

  2009cited by this paper
• Advances in hormone replacement therapy with drospirenone, a unique progestogen with aldosterone receptor antagonism.

  2006cited by this paper
• Conjugated equine estrogens and coronary heart disease: the Women's Health Initiative.

  2006cited by this paper
• Effects of Aldosterone on the Vasculature

  2006cited by this paper
• Menopausal hormone therapy.

  2005cited by this paper
• Effects of drospirenone/17-beta estradiol on blood pressure and potassium balance in hypertensive postmenopausal women.

  2005cited by this paper
• Estradiol and drospirenone for climacteric symptoms in postmenopausal women: a double-blind, randomized, placebo-controlled study of the safety and efficacy of three dose regimens

  2004cited by this paper
• Effects of conjugated equine estrogen in postmenopausal women with hysterectomy

  2004cited by this paper
• Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence.

  2004cited by this paper
• Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial

  2004cited by this paper
• Myocardial blood flow and flow reserve in response to hormone therapy in postmenopausal women with risk factors for coronary disease.

  2004cited by this paper
• Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction.

  2003cited by this paper
• Pharmacology of estradiol valerate/dienogest.

  2003cited by this paper
• Pharmacokinetics and Potency of Progestins used for Hormone Replacement Therapy and Contraception

  2002cited by this paper
• Noninvasive Assessment of Coronary Microcirculatory Function in Postmenopausal Women and Effects of Short-Term and Long-Term Estrogen Administration

  2002cited by this paper
• Effect of Medroxyprogesterone Acetate on Vascular Inflammatory Markers in Postmenopausal Women Receiving Estrogen

  2002cited by this paper
• Carotid artery intima thickness and flow velocity after discontinuation of hormone replacement therapy in postmenopausal women: follow-up study.

  2001cited by this paper
• Myocardial blood flow and flow reserve in response to short-term cyclical hormone replacement therapy in postmenopausal women.

  2001cited by this paper
• Essential hypertension. Part I: definition and etiology.

  2000cited by this paper
• A comparative investigation of contraceptive reliability, cycle control and tolerance of two monophasic oral contraceptives containing either drospirenone or desogestrel

  2000cited by this paper
• Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular Health Study Collaborative Research Group.

  1999cited by this paper
• Hormone Replacement Therapy and Circulating ICAM-1 in Postmenopausal Women

  1999cited by this paper
• Women and heart disease

  1998cited by this paper
• Medroxyprogesterone acetate antagonizes inhibitory effects of conjugated equine estrogens on coronary artery atherosclerosis.

  1997cited by this paper
• Relation of intima-media thickness to atherosclerotic plaques in carotid arteries. The Vascular Aging (EVA) Study.

  1996cited by this paper
• Antiatherosclerotic effects of antihypertensive drugs: recent evidence and ongoing trials.

  1996cited by this paper
• Age at menopause as a risk factor for cardiovascular mortality.

  1996cited by this paper
• Hormone replacement therapy is associated with improved arterial physiology in healthy post‐menopausal women

  1996cited by this paper
• Hormone replacement therapy lowers plasma Lp(a) concentrations. Comparison of cyclic transdermal and continuous estrogen-progestin regimens.

  1996cited by this paper
• Estrogen Replacement Therapy and Progression of Intimal-Medial Thickness in the Carotid Arteries of Postmenopausal Women

  1995cited by this paper
• Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism.

  1995cited by this paper
• THE METABOLIC AND CARDIOVASCULAR CONSEQUENCES OF HRT

  1995cited by this paper
• Combined oestrogen-progestin replacement therapy prevents atherosclerosis in postmenopausal women.

  1995cited by this paper
• Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial. The Writing Group for the PEPI Trial.

  1995cited by this paper
• Estrogen replacement therapy and progression of intimal-medial thickness in the carotid arteries of postmenopausal women. ACAPS Investigators. Asymptomatic Carotid Atherosclerosis Progression Study.

  1995cited by this paper
• Effects of Estrogen or Estrogen/ Progestin Regimens on Heart Disease Risk Factors in Postmenopausal Women: The Postmenopausal Estrogen/Progestin Interventions (PEPI) Trial

  1995cited by this paper
• Oestrogen and inhibition of oxidation of low-density lipoproteins in postmenopausal women.

  1994cited by this paper
• Isolated systolic hypertension and vessel wall thickness of the carotid artery. The Rotterdam Elderly Study.

  1993cited by this paper
• Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women

  1992cited by this paper
• Assessment of the risk of post-menopausal osteoporosis using clinical factors.

  1992cited by this paper
• Assessment of the risk of post‐menopausal osteoporosis using clinical factors

  1992cited by this paper
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence☆☆☆

  1991cited by this paper
• Estrogen and coronary heart disease in women

  1991cited by this paper
• Evaluation of the associations between carotid artery atherosclerosis and coronary artery stenosis. A case-control study.

  1990cited by this paper
• Menopause and the risk of coronary heart disease in women.

  1987cited by this paper
• Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging.

  1986cited by this paper

• Hormone Replacement Therapy and Cardiovascular Health in Postmenopausal Women

  2025cites this paper
• Menopause-related changes in vascular signaling by sex hormones.

  2025cites this paper
• Gender-Based Research Underscores Sex Differences in Biological Processes, Clinical Disorders and Pharmacological Interventions.

  2023cites this paper
• Association between hormone replacement therapy and sex hormones in postmenopausal women: a systematic review and meta-analysis.

  2023cites this paper
• The 2022 hormone therapy position statement of The North American Menopause Society

  2022cites this paper
• Can Type of Dizziness Influence the Vestibular Caloric Test Result?

  2021cites this paper
• Improving the quality of life in menopausal women. An overview of menopausal hormone therapy possibilities

  2019cites this paper
• УЛУЧШЕНИЕ КАЧЕСТВА ЖИЗНИ ЖЕНЩИНЫ В КЛИМАКТЕРИИ. ОБЗОР ВОЗМОЖНОСТЕЙ МЕНОПАУЗАЛЬНОЙ ГОРМОНАЛЬНОЙ ТЕРАПИИ

  2019cites this paper
• The Effects of Systemic Disease on the Benign Paroxismal Positional Vertigo Attacks

  2018cites this paper
• The 2017 hormone therapy position statement of The North American Menopause Society

  2018cites this paper
• Recovery Phase Spontaneous Nystagmus, Its Existence and Clinical Implication

  2018cites this paper
• Age-Related Increases in Benign Paroxysmal Positional Vertigo Are Reversed in Women Taking Estrogen Replacement Therapy: A Population-Based Study in Taiwan

  2017cites this paper
• The 2017 hormone therapy position statement of The North American Menopause Society

  2017cites this paper
• The "newer" progestogens and postmenopausal hormone therapy (HRT).

  2014cites this paper
• Estrogen, vascular estrogen receptor and hormone therapy in postmenopausal vascular disease.

  2013cites this paper
• Vascular effects of estrogenic menopausal hormone therapy.

  2012cites this paper